SBL
CABA icon

Sargent Bickham Lagudis’s Cabaletta Bio CABA Stock Holding History

Sargent Bickham Lagudis’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$2K – 936
2021
Q1 		$2K Hold
200
– – ﹤0.01% 853
2020
Q4 		$2K Hold
200
– – ﹤0.01% 802
2020
Q3 		$2K Buy
+200
New +$2.3K ﹤0.01% 719

Other funds holding CABA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sargent Bickham Lagudis's CABA Position: Q2 2021 in Review

Sargent Bickham Lagudis sold out of Cabaletta Bio (CABA) in Q2 2021, closing a stake of 200 shares — an estimated $2K sold.

Sargent Bickham Lagudis first reported a position in CABA in Q3 2020 and held it in 3 quarters. The position peaked at $2K in Q1 2021. 63 funds tracked by Wall St. Rank hold CABA as of Q2 2021.

  • Sargent Bickham Lagudis reported no remaining Cabaletta Bio position as of Q2 2021 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 200 Cabaletta Bio shares in Q2 2021, an estimated $2K.
  • Sargent Bickham Lagudis first reported a position in Cabaletta Bio in Q3 2020 and held it in 3 quarters.
  • Sargent Bickham Lagudis's Cabaletta Bio position peaked at $2K in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2021.

Based on Sargent Bickham Lagudis's 13F filing for Q2 2021, filed 19 Jul 2021.